168 related articles for article (PubMed ID: 29061463)
1. Presentation, Treatment, and Long-Term Outcome of Intrasellar Chordoma: A Pooled Analysis of Institutional, SEER (Surveillance Epidemiology and End Results), and Published Data.
Ahmed AK; Dawood HY; Arnaout OM; Laws ER; Smith TR
World Neurosurg; 2018 Jan; 109():e676-e683. PubMed ID: 29061463
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
3. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
4. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy After Gross Total Resection of Skull Base Chordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes.
Gendreau J; Jimenez A; Lozinsky S; Zenonos G; Gardner P; Raza S; Dea N; Gokaslan Z; Choby G; Van Gompel J; Redmond K; Gallia G; Bettegowda C; Rowan N; Kuo CC; Mukherjee D
World Neurosurg; 2023 Apr; 172():e68-e76. PubMed ID: 36509323
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
9. Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.
Tian K; Zhang H; Ma J; Wang K; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J; Wang L
World Neurosurg; 2017 Jan; 97():39-48. PubMed ID: 27671886
[TBL] [Abstract][Full Text] [Related]
10. Extent of surgical resection and tumor size predicts prognosis in granular cell tumor of the sellar region.
Ahmed AK; Dawood HY; Penn DL; Smith TR
Acta Neurochir (Wien); 2017 Nov; 159(11):2209-2216. PubMed ID: 28948361
[TBL] [Abstract][Full Text] [Related]
11. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
12. Cranial base chordoma--long term outcome and review of the literature.
Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
[TBL] [Abstract][Full Text] [Related]
13. Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches.
Brown NJ; Gendreau J; Kuo CC; Nguyen O; Yang C; Catapano JS; Lawton MT
J Neurooncol; 2023 Oct; 165(1):41-51. PubMed ID: 37880419
[TBL] [Abstract][Full Text] [Related]
14. [Treatment modalities and prognostic factors of chordoma in the skull base].
Qian LT; Liu XF; Li YX
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):635-7. PubMed ID: 16438879
[TBL] [Abstract][Full Text] [Related]
15. Skull base chondroid chordoma: atypical case manifesting as intratumoral hemorrhage and literature review.
Tsutsumi S; Akiba C; Suzuki T; Nakanishi H; Izumi H; Yasumoto Y; Ito M
Clin Neuroradiol; 2014 Dec; 24(4):313-20. PubMed ID: 25070287
[TBL] [Abstract][Full Text] [Related]
16. Cranial base chordomas.
Menezes AH; Gantz BJ; Traynelis VC; McCulloch TM
Clin Neurosurg; 1997; 44():491-509. PubMed ID: 10080023
[No Abstract] [Full Text] [Related]
17. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
18. Intrasellar Chordoma Mimicking Pituitary Macroadenoma with Hyperprolactinemia and Hypopituitarism: Clinical Images with a Surgical Video.
Fujita Y; Uozumi Y; Sasayama T
World Neurosurg; 2023 Feb; 170():158-162. PubMed ID: 36375800
[TBL] [Abstract][Full Text] [Related]
19. SNF5 as a prognostic factor in skull base chordoma.
Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y
J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
